COVID-19 treatment

6:00am Jan 12, 2022

Health & Safety Health & Safety

Omicron is driving test and treatment shortages — what this means for the Triad

by April Laissle

The omicron variant of COVID-19 has driven a massive surge in case numbers that has Triad health care providers desperate for relief.
Merck & Co., Inc.

2:42pm Dec 23, 2021

National National Science Health & Safety

The FDA has authorized Merck's COVID pill for home use — the 2nd in 2 days

The medicine, called molnupiravir, is taken twice a day for five days and works by preventing the virus from replicating. Merck says it will have 10 million packs available by the end of the month.
Merck & Co Inc./Handout via Reuters

6:18pm Nov 30, 2021

Health & Safety Health & Safety

An FDA panel supports Merck COVID drug in mixed vote

by Scott Hensley

If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.
11:12am Sep 03, 2021

Health & Safety Health & Safety

Tested Positive For COVID-19? Here's What You Need To Know About Monoclonal Antibody Treatments

by April Laissle

As the delta variant continues to drive record case numbers and hospitalizations, monoclonal antibody treatments for the virus are becoming increasingly popular.

Listen
Tara Pixley for NPR

7:01am May 22, 2021

Health & Safety Health & Safety

After Months Of A Racing Heart And Burning Feet, A COVID Long-Hauler Gets A Diagnosis

by Allison Aubrey

Jennifer Minhas is among those who suffer lingering problems after COVID-19. A diagnosis of POTS, a little-known circulation disorder that mostly affects women, offers a way forward.
10:56am Apr 16, 2021

Health & Safety Health & Safety

Antibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges

by Richard Harris

Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.

Listen
Ariana Drehsler / AFP via Getty Images

7:05am Jan 22, 2021

Health & Safety Health & Safety

After A Year Battling COVID-19, Drug Treatments Get A Mixed Report Card

by Richard Harris

Drugs for COVID-19 are sorted into three basic categories: They work, they don't work, or there simply isn't enough information to know. A generic steroid is one medicine that proved helpful.

Listen
Irfan Khan / Los Angeles Times via Getty Images

6:43pm Jan 11, 2021

Health & Safety Health & Safety

Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients

by Richard Harris

Antibody-based drugs that bind to the coronavirus to prevent it from invading cells can help patients with mild to moderate COVID-19. But the medicines can be tough to find in time.

Listen
Alex Brandon / AP

11:01am Dec 22, 2020

Health & Safety Health & Safety

Low Demand For Antibody Drugs Against COVID-19

by Richard Harris

Monoclonal antibodies to prevent severe COVID-19 aren't being used as widely as expected. Medical staff shortages and patient transportation problems are two of the reasons.

Listen
Mario Tama / Getty Images

5:56pm Oct 20, 2020

Health & Safety Health & Safety

Studies Point To Big Drop In COVID-19 Death Rates

by Geoff Brumfiel

More hospitalized patients are surviving than early in the pandemic. Improved treatments make a big difference, but so does flattening the curve to keep hospitals from overfilling, researchers say.

Listen
4:41pm Sep 29, 2020

News News Health & Safety

Wake Forest Baptist Health Enrolling Patients in COVID-19 Drug Treatment Trial

by April Laissle

Wake Forest Baptist Health is enrolling patients in a new Phase 2 clinical trial to determine whether drugs already in use could be repurposed to treat COVID-19.

COVID-19 treatment

Omicron is driving test and treatment shortages — what this means for the Triad

The FDA has authorized Merck's COVID pill for home use — the 2nd in 2 days

An FDA panel supports Merck COVID drug in mixed vote

Tested Positive For COVID-19? Here's What You Need To Know About Monoclonal Antibody Treatments

After Months Of A Racing Heart And Burning Feet, A COVID Long-Hauler Gets A Diagnosis

Antibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges

After A Year Battling COVID-19, Drug Treatments Get A Mixed Report Card

Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients

Low Demand For Antibody Drugs Against COVID-19

Studies Point To Big Drop In COVID-19 Death Rates

Wake Forest Baptist Health Enrolling Patients in COVID-19 Drug Treatment Trial

Shows

Support WFDD

Underwriting

About WFDD